| Bookmark Site | Bookmark Page |

 
 
 
Modapro - All over again Waken the Agent of Promotion

 
Modapro - the novel, later the advanced trace advancing the agent, chemically untied with amphetamines which operates on the defined areas in previous hypothalamus.

Modapro - a unique advancing trace the agent, approved USA FDA to improve awake in patients with the excessive day time drowsiness connected with narcolepsy, the handicap sleeps apnoea/hypopnoea a syndrome (OSAHS) and change in work of the disorder of dream.

Its pharmacological properties are distinct from those from others CNS stimulants;
It selectively tracks the neuronal purposes in a sleeping cycle of a brain. It is especially attractive alternative to other stimulants because of its limited and the soft structure of a side effect and low abuses potential.

Its exact mechanism of action is not known, but there is a certificate, that it constant drowsiness in patients, complying nasal CPAP (continuous confident reduces pressure of an air line) therapy.

Modapro copes in a dose of 200-400 mg once daily in the morning
also it is designated as additional therapy for excessive day time drowsiness at patients with OSA.